Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoChange DetectedThe date has been updated from February 28, 2025, to April 20, 2025.SummaryDifference0.7%
- Check22 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.SummaryDifference1.0%
- Check66 days agoChange DetectedThe date has been updated from November 13, 2024, to February 28, 2025.SummaryDifference1.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.